Helmerich & Payne target price cut to $48 from $49 by TD Cowen
HP•TD Cowen cut its target price for Helmerich & Payne to $48 from $49.
Related News

Praxis Precision Medicines initiated with buy rating and $713 price target
PRAX•

Baidu files HKEX next day disclosure return on share buyback for cancellation
BIDU•

Shenzhen three-power summit masks bilateral limits
UNG•

Australian dollar hits 11-month low, kiwi at six-year trough
TLT•

Anthropic, PBC: Seaport Research Partners assigns neutral rating to the stock
ANT•